The Therapeutic Drug Monitoring (TDM) test market is booming, reaching $2 billion in 2025 and projected to grow at a 5% CAGR. Discover key drivers, trends, restraints, and regional analysis for this rapidly expanding sector, including insights on blood, urine, and saliva tests, and leading companies like Roche and Abbott.
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.
